Gelteq Limited Ordinary Shares (GELS NASDAQ) stock market data APIs
$1.4132
0.21(14.9%)
as of September 15, 2025
Try our APIs with
free plan!
Gelteq Limited Ordinary Shares Financial Data Overview
Price chart is built with
Anychart
Gelteq Limited focuses on developing, testing, and commercializing white label gel-based delivery solutions for humans and animals in Asia-Pacific Region. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. The company has a strategic alliance with IDT Australia Limited for the development and scale up of its gel-based products across diverse global pharmaceutical, nutraceutical and animal health markets. Gelteq Limited was incorporated in 2017 and is headquartered in Caulfield, Australia.
Prev. Close
1.4132
Open
1.6187
High
1.6187
Low
1.4132
52 wk Range
0.77-5.5
Market Cap
14 240 K
Shares Outstanding
10 028 K
Revenue
378 K
EPS
-0.38
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Gelteq Limited Ordinary Shares data using free add-ons & libraries
Get Gelteq Limited Ordinary Shares Fundamental Data
Gelteq Limited Ordinary Shares Fundamental data includes:
- Net Revenue: 378 K
- EBITDA: -2 323 691
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-06-30
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Gelteq Limited Ordinary Shares News
New
Gelteq Technology Powers U.S. Product Launches of its Nutraceutical Products for Partner
MELBOURNE, Australia, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company,” NASDAQ: GELS), a clinical and science-based developer of gel-based oral delivery solutions...
Top Midday Gainers
SINTX Technologies (SINT) said Wednesday it published a peer-reviewed study demonstrating that silic PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Friday's session: top gainers and losers
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis. [topmovers] TODAY'S TOP GAINERS TICKE...
Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market
MELBOURNE, Australia, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based company specialising in gel-based oral delivery solutions, t...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
